Abstract
Topical steroid damaged/dependent face (TSDF) is a syndrome complex first described by Lahiri and Coondoo in 2008. It is caused by unsupervised application of topical corticosteroids (TCs) of the wrong potency over a prolonged period of time on the face. This abuse, misuse or overuse results in damage to the skin of the face as well as a severe pharmaco-dependence on the TC. The combined effect of this damage and dependence severely affects the quality of life (QoL) of the patient. Management of TSDF is difficult and necessitates both physical treatment of the skin and psychological counselling to improve the psyche of the patient.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lahiri K, Coondoo A. Topical steroid damaged/dependent face (TSDF): an entity of cutaneous pharmacodependence. Indian J Dermatol. 2016;61:265–72.
Sulzberger MB, Witten VH. The effect of topically applied compound F in selected dermatoses. J Invest Dermatol. 1952;19(2):101–2.
Epstein NN, Epstein WL, Epstein JH. Atrophic striae in patients with inguinal intertrigo. Arch Dermatol. 1963;87:450–7.
Burry JN. Topical drug addiction: adverse effects of fluorinated corticosteroid creams and ointments. Med J Austr. 1973;1:393–6.
Kligman AM. Topical steroid addicts. JAMA. 1976;235:1550.
Juzbasić A, Subić JS, Ljubojević S. Demodex folliculorum in development of dermatitis rosaceiformis steroidica and rosacea-related diseases. Clin Dermatol. 2002;20(2):135–40.
Rapaport MJ, Rapaport V. The red skin syndromes: corticosteroid addiction and withdrawal. Expert Rev Dermatol. 2006;1:547–61.
Rathi SK, Kumrah L. Topical corticosteroid-induced rosacea-like dermatitis: a clinical study of 110 cases. Indian J Dermatol Venereol Leprol. 2011;77:42–6.
Rathi S. Abuse of topical steroid as cosmetic cream: a social background of steroid dermatitis. Indian J Dermatol. 2006;51:154–5.
Coondoo A. Topical steroid misuse: the Indian scenario. Indian J Dermatol. 2014;59:451–5.
Saraswat A, Lahiri K, Chatterjee M, Barua S, Coondoo A, Mittal A, et al. Topical corticosteroid abuse on the face: a prospective, multicentre study of dermatology outpatients. Indian J Dermatol Venereol Leprol. 2011;77:160–6.
Rathi S, D’Souza P. Rational and ethical use of topical corticosteroids based on safety and efficacy. Indian J Dermatol. 2012;57(4):251–9.
Ambika H, Sujatha VC, Yadalla H, et al. Topical corticosteroid abuse on face: a prospective study on outpatients of dermatology. Dermatol Online. 2014;5(1):5–8.
Saraswat A. Topical corticosteroid use in children: adverse effects and how to minimize them. Indian J Dermatol Venereol Leprol. 2010;76:225–8.
Coondoo A, Chattopadhyay C. Use and abuse of topical corticosteroids in children. Indian J Paediatr Dermatol. 2014;15:1–4.
Saraswat A. Ethical use of topical corticosteroids. Indian J Dermatol. 2014;59:469–72.
Ghosh A, Sengupta S, Coondoo A, Jana AK. Topical corticosteroid addiction and phobia. Indian J Dermatol. 2014;59:465–8.
Verma SB. Sales, status, prescriptions and regulatory problems with topical steroids in India. Indian J Dermatol Venereol Leprol. 2014;80:201–3.
Dey VK. Misuse of topical corticosteroids: a clinical study of adverse effects. Indian Dermatol Online J. 2014;5:436–40.
Verma SB. Topical corticosteroid misuse in India is harmful and out of control. BMJ. 2015;351:h6079.
Fisher M. Steroid-induced rosacealike dermatitis: case report and review of the literature. Cutis. 2009;83:198–204.
Abraham A, Roga G. Topical steroid damaged skin. Indian J Dermatol. 2014;59(5):456–9.
Coondoo A, Phiske M, Verma S, Lahiri K. Side-effects of topical corticosteroids. A long overdue revisit. Indian Dermatol Online J. 2014;5:416–25.
Saraswat A. Contact allergy to topical corticosteroids and sunscreens. Indian J Dermatol Venereol Leprol. 2012;78:552–9.
Goldman D. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol. 2001;44:995–8.
Chu CY. An open-label pilot study to evaluate the safety and the efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption. J Eur Aca Dermatol Venereol. 2007;21:484–9.
Warnecke J, Wendt A. Anti-inflammatory action of pale sulfonated shale oil (ICHTHYOL pale) in UVB erythema test. Inflamm Res. 1998;47(2):75–8.
Korting HC, Schöllmann C, Cholcha W, Wolff L, The Collaborative Study Group. Efficacy and tolerability of pale sulfonated shale oil cream 4% in the treatment of mild to moderate atopic eczema in children: a multicentre, randomized vehicle-controlled trial. J Eur Acad Dermatol Venereol. 2010;24:1176–82.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Coondoo, A., Lahiri, K. (2018). Topical Steroid Damaged/Dependent Face (TSDF). In: Lahiri, K. (eds) A Treatise on Topical Corticosteroids in Dermatology. Springer, Singapore. https://doi.org/10.1007/978-981-10-4609-4_13
Download citation
DOI: https://doi.org/10.1007/978-981-10-4609-4_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-4608-7
Online ISBN: 978-981-10-4609-4
eBook Packages: MedicineMedicine (R0)